Skip to main content
Erschienen in: Abdominal Radiology 5/2012

01.10.2012

CT and enhanced CT in diagnosis of gastrointestinal neuroendocrine carcinomas

verfasst von: Dan Wang, Guo-Bin Zhang, Lei Yan, Xiao-Er Wei, Yu-Zhen Zhang, Wen-Bin Li

Erschienen in: Abdominal Radiology | Ausgabe 5/2012

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To enhance diagnosis of gastrointestinal neuroendocrine carcinomas using CT and contrast-enhanced CT images.

Methods

A total of 44 patients with gastrointestinal neuroendocrine carcinomas, as confirmed by clinical pathology and immunohistochemistry in the Sixth Affiliated People’s Hospital of Shanghai Jiao Tong University Shanghai China, were included in the study. CT and enhanced CT scanning were performed, and the resulting images were reviewed and analyzed.

Results

Twenty-seven males and 17 females were enrolled. Gastrointestinal involvement included the following: 5 cases located in the middle or inferior segment of the esophagus; 5 in the gastric cardia, 15 in the body of stomach, 6 located in the gastric antrum; 5 located in the Vater papilla of the duodenum; and 8 located in the colon. Among the 44 cases 80%–90% of the lesions had homogeneous density. Totally 81.8% (36/44) cases demonstrated homogeneous enhancement in arterial phases, most of the cases (n = 33) moderately or obviously enhanced. Only 17.2% (8/44) cases appeared as heterogeneous enhancement. And 86.4% cases (n = 38) were further enhanced in the venous phase. The CT images also revealed some of the metastases. Some liver metastasis cases have obvious homogeneous enhancement.

Conclusions

CT and enhanced CT provide useful information regarding gastrointestinal neuroendocrine carcinomas’ location, density, enhancement pattern, and some metastasis. These features are helpful to increase the diagnostic accuracy.
Literatur
1.
Zurück zum Zitat Musialik JA, Kohut MJ, Marek T, Wodolazski A, Hartleb M (2009) Composite neuroendocrine and adenomatous carcinoma of the papilla of Vater. World J Gastroenterol 15(33):4199–4200CrossRefPubMedPubMedCentral Musialik JA, Kohut MJ, Marek T, Wodolazski A, Hartleb M (2009) Composite neuroendocrine and adenomatous carcinoma of the papilla of Vater. World J Gastroenterol 15(33):4199–4200CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Helpap B, Kollermann J (2001) Immunohistochemical analysis of the proliferative activity of neuroendocrine tumors from various organs. Are there indications for a neuroendocrine tumor-carcinoma sequence? Virchows Arch 438(1):86–91CrossRefPubMed Helpap B, Kollermann J (2001) Immunohistochemical analysis of the proliferative activity of neuroendocrine tumors from various organs. Are there indications for a neuroendocrine tumor-carcinoma sequence? Virchows Arch 438(1):86–91CrossRefPubMed
3.
Zurück zum Zitat Kloppel G, Perren A, Heitz PU (2004) The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Ann N Y Acad Sci 1014:13–27CrossRefPubMed Kloppel G, Perren A, Heitz PU (2004) The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Ann N Y Acad Sci 1014:13–27CrossRefPubMed
6.
Zurück zum Zitat Cwikla JB, Nasierowska-Guttmejer A, Jeziorski KG, et al. (2007) Diagnostic imaging approach to gastro-entero-pancreatic carcinomas of neuroendocrine origin—single NET center experience in Poland. Neuro Endocrinol Lett 28(6):789–800PubMed Cwikla JB, Nasierowska-Guttmejer A, Jeziorski KG, et al. (2007) Diagnostic imaging approach to gastro-entero-pancreatic carcinomas of neuroendocrine origin—single NET center experience in Poland. Neuro Endocrinol Lett 28(6):789–800PubMed
7.
Zurück zum Zitat Formica V, Wotherspoon A, Cunningham D, et al. (2007) The prognostic role of WHO classification, urinary 5-hydroxyindoleacetic acid and liver function tests in metastatic neuroendocrine carcinomas of the gastroenteropancreatic tract. Br J Cancer 96(8):1178–1182. doi:10.1038/sj.bjc.6603699 CrossRefPubMedPubMedCentral Formica V, Wotherspoon A, Cunningham D, et al. (2007) The prognostic role of WHO classification, urinary 5-hydroxyindoleacetic acid and liver function tests in metastatic neuroendocrine carcinomas of the gastroenteropancreatic tract. Br J Cancer 96(8):1178–1182. doi:10.​1038/​sj.​bjc.​6603699 CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Haeubl M, Schuerz S, Svejda B, et al. (2010) Asymmetrically substituted cationic indole- and fluorene porphyrins inhibit tumor proliferation in small intestinal neuroendocrine tumors and medullary thyroid carcinomas. Eur J Med Chem 45(2):760–773. doi:10.1016/j.ejmech.2009.11.025 CrossRefPubMed Haeubl M, Schuerz S, Svejda B, et al. (2010) Asymmetrically substituted cationic indole- and fluorene porphyrins inhibit tumor proliferation in small intestinal neuroendocrine tumors and medullary thyroid carcinomas. Eur J Med Chem 45(2):760–773. doi:10.​1016/​j.​ejmech.​2009.​11.​025 CrossRefPubMed
11.
Zurück zum Zitat Owen NJ, Sohaib SA, Peppercorn PD, et al. (2001) MRI of pancreatic neuroendocrine tumours. Br J Radiol 74(886):968–973CrossRefPubMed Owen NJ, Sohaib SA, Peppercorn PD, et al. (2001) MRI of pancreatic neuroendocrine tumours. Br J Radiol 74(886):968–973CrossRefPubMed
12.
13.
Zurück zum Zitat Moran CA, Suster S (2007) Neuroendocrine carcinomas (carcinoid, atypical carcinoid, small cell carcinoma, and large cell neuroendocrine carcinoma): current concepts. Hematol Oncol Clin N Am 21(3):395–407. doi:10.1016/j.hoc.2007.04.011 Moran CA, Suster S (2007) Neuroendocrine carcinomas (carcinoid, atypical carcinoid, small cell carcinoma, and large cell neuroendocrine carcinoma): current concepts. Hematol Oncol Clin N Am 21(3):395–407. doi:10.​1016/​j.​hoc.​2007.​04.​011
14.
16.
Zurück zum Zitat Panzuto F, Nasoni S, Falconi M, et al. (2005) Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization. Endocr Relat Cancer 12(4):1083–1092. doi:10.1677/erc.1.01017 CrossRefPubMed Panzuto F, Nasoni S, Falconi M, et al. (2005) Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization. Endocr Relat Cancer 12(4):1083–1092. doi:10.​1677/​erc.​1.​01017 CrossRefPubMed
17.
Zurück zum Zitat Nagaraj N, Egwim C, Adler DG (2007) X-linked hyper-IgM syndrome associated with poorly differentiated neuroendocrine tumor presenting as obstructive jaundice secondary to extensive adenopathy. Dig Dis Sci 52(9):2312–2316. doi:10.1007/s10620-006-9702-3 CrossRefPubMed Nagaraj N, Egwim C, Adler DG (2007) X-linked hyper-IgM syndrome associated with poorly differentiated neuroendocrine tumor presenting as obstructive jaundice secondary to extensive adenopathy. Dig Dis Sci 52(9):2312–2316. doi:10.​1007/​s10620-006-9702-3 CrossRefPubMed
18.
Zurück zum Zitat Dong RZ, Shi YQ, Ye YW, Fu H, Zhao GF (2010) Clinicopathological and prognostic analysis of 23 poorly differentiated neuroendocrine carcinomas of the stomach. Zhonghua Wei Chang Wai Ke Za Zhi 13(8):583–586PubMed Dong RZ, Shi YQ, Ye YW, Fu H, Zhao GF (2010) Clinicopathological and prognostic analysis of 23 poorly differentiated neuroendocrine carcinomas of the stomach. Zhonghua Wei Chang Wai Ke Za Zhi 13(8):583–586PubMed
20.
Zurück zum Zitat Kaltsas G, Rockall A, Papadogias D, Reznek R, Grossman AB (2004) Recent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumours. Eur J Endocrinol 151(1):15–27CrossRefPubMed Kaltsas G, Rockall A, Papadogias D, Reznek R, Grossman AB (2004) Recent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumours. Eur J Endocrinol 151(1):15–27CrossRefPubMed
21.
Zurück zum Zitat Pape UF, Berndt U, Muller-Nordhorn J, et al. (2008) Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours. Endocr Relat Cancer 15(4):1083–1097. doi:10.1677/ERC-08-0017 CrossRefPubMed Pape UF, Berndt U, Muller-Nordhorn J, et al. (2008) Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours. Endocr Relat Cancer 15(4):1083–1097. doi:10.​1677/​ERC-08-0017 CrossRefPubMed
23.
Zurück zum Zitat Badea R, Seicean A, Diaconu B, et al. (2009) Contrast-enhanced ultrasound of the pancreas—a method beyond its potential or a new diagnostic standard? J Gastrointestin Liver Dis 18(2):237–242PubMed Badea R, Seicean A, Diaconu B, et al. (2009) Contrast-enhanced ultrasound of the pancreas—a method beyond its potential or a new diagnostic standard? J Gastrointestin Liver Dis 18(2):237–242PubMed
25.
27.
Zurück zum Zitat Debray MP, Geoffroy O, Laissy JP, et al. (2001) Imaging appearances of metastases from neuroendocrine tumours of the pancreas. Br J Radiol 74(887):1065–1070CrossRefPubMed Debray MP, Geoffroy O, Laissy JP, et al. (2001) Imaging appearances of metastases from neuroendocrine tumours of the pancreas. Br J Radiol 74(887):1065–1070CrossRefPubMed
Metadaten
Titel
CT and enhanced CT in diagnosis of gastrointestinal neuroendocrine carcinomas
verfasst von
Dan Wang
Guo-Bin Zhang
Lei Yan
Xiao-Er Wei
Yu-Zhen Zhang
Wen-Bin Li
Publikationsdatum
01.10.2012
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 5/2012
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-011-9836-4

Weitere Artikel der Ausgabe 5/2012

Abdominal Radiology 5/2012 Zur Ausgabe

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.